Congenital diaphragmatic hernia-associated cardiac dysfunction

Area of Science:

• Pediatric Cardiology
• Neonatal Physiology
• Congenital Diaphragmatic Hernia Research

Background:

• Congenital diaphragmatic hernia (CDH) is a complex condition with significant neonatal morbidity and mortality.
• Cardiac dysfunction, affecting both ventricles, is increasingly recognized as a critical component of CDH pathophysiology.
• Ventricular dysfunction in CDH is linked to disease severity, increased need for extracorporeal membrane oxygenation (ECMO), and adverse outcomes.

Purpose of the Study:

• To highlight the pivotal role of cardiac dysfunction in congenital diaphragmatic hernia (CDH).
• To emphasize the importance of early and routine assessment of ventricular function and pulmonary artery pressure in CDH management.
• To explore how optimizing cardiac function may improve clinical outcomes for CDH patients.

Main Methods:

• Review of current evidence linking cardiac dysfunction to CDH pathophysiology and outcomes.
• Analysis of the clinical implications of early ventricular function and pulmonary artery pressure assessment.
• Discussion of potential therapeutic strategies targeting cardiac dysfunction in CDH.

Main Results:

• Cardiac dysfunction is a common and significant issue in neonates with CDH.
• Early assessment of cardiac parameters can inform critical clinical decisions.
• Adverse outcomes such as mortality and need for ECMO are associated with cardiac dysfunction in CDH.

Conclusions:

• Routine cardiac assessment in CDH is crucial for guiding individualized treatment strategies.
• Interventions aimed at minimizing cardiac dysfunction, through prenatal, perinatal, or postnatal means, hold promise for improving CDH outcomes.
• Addressing cardiac dysfunction is a key therapeutic target for enhancing survival and reducing morbidity in congenital diaphragmatic hernia.